Flexion Therapeutics, Inc. (FLXN)

11.98
NASDAQ
Prev Close 11.97
Day Low/High 11.64 / 12.10
52 Wk Low/High 5.01 / 22.98
Exchange NASDAQ
Shares Outstanding 49.30B
Market Cap 590.16M
P/E Ratio N/A
Div & Yield N.A. (N.A)
3 Small Biotech Stocks Insiders Are Buying

3 Small Biotech Stocks Insiders Are Buying

Verastem Inc., Pieris Pharmaceuticals and Intra-Cellular Therapies all have promising products.

These 4 Small Biotechs Have Big Upcoming Catalysts

These 4 Small Biotechs Have Big Upcoming Catalysts

Zogenix, Flexion, Dynavax and Progenics all have potential upside on these events.

4 Small Biotechs With Big Catalysts

4 Small Biotechs With Big Catalysts

Zogenix, Flexion, Dynavax and Progenics all have potential upside on upcoming events.

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

As with Adamas Pharmaceuticals, circling key milestone dates on your calendar can prove beneficial.

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

As with Adamas Pharmaceuticals, circling key milestone dates on your calendar can prove beneficial.

2 Biotechs That Could Flex Their Muscles

2 Biotechs That Could Flex Their Muscles

Flexion Therapeutics and Adamis Pharmaceuticals are names to like at current levels.

2 Recovering Biotech Names With Room to Run

2 Recovering Biotech Names With Room to Run

There are reasons to believe rallies in BioDelivery Sciences and Flexion Therapeutics should continue.

4 Undervalued Biotech Stocks

4 Undervalued Biotech Stocks

Two are turnaround stories, and two are oversold.

2 Oversold Biopharmas With Big 2017 Upsides

2 Oversold Biopharmas With Big 2017 Upsides

Flexion Therapeutics and BioDelivery Sciences are well below what they once fetched.

Shark Bites: You Don't Want to Play the Gambler Today

Shark Bites: You Don't Want to Play the Gambler Today

This is one of those days when it may pay to walk away.

Second-Quarter Picks and Pans

Second-Quarter Picks and Pans

Las Vegas Sands and Flexion are in, and the autos are out.

I'm Big on Housing Entering Quarter No. 2

I'm Big on Housing Entering Quarter No. 2

Home builders make up the second-largest allocation in my portfolio, behind biotech.

How I'd Play Biotech Buyout Rumors

How I'd Play Biotech Buyout Rumors

Answering questions from the Biotech Mailbag on FLXN and SGYP.

How I'd Play Biotech Buyout Rumors

How I'd Play Biotech Buyout Rumors

Answering questions from the Biotech Mailbag on FLXN and SGYP.

Health Care Vote Impacts Trump's Deal Maker Image

Health Care Vote Impacts Trump's Deal Maker Image

At stake is whether the Republicans can work out their differences.

Seeing Some Good Action in Individual Stocks

Seeing Some Good Action in Individual Stocks

An update on the market and my stock of the week, TPI Composites.

Market Digging Metal and Mining Stocks

There is some good speculative trading and metals are the place to be.